10,920 Shares in Colgate-Palmolive (NYSE:CL) Acquired by VCI Wealth Management LLC

VCI Wealth Management LLC bought a new stake in shares of Colgate-Palmolive (NYSE:CL) during the fourth quarter, Holdings Channel.com reports. The fund bought 10,920 shares of the company’s stock, valued at approximately $870,000.

A number of other hedge funds and other institutional investors have also bought and sold shares of the business. Syon Capital LLC raised its holdings in Colgate-Palmolive by 89.9% during the 4th quarter. Syon Capital LLC now owns 7,394 shares of the company’s stock valued at $589,000 after acquiring an additional 3,501 shares during the period. Bailard Inc. raised its holdings in Colgate-Palmolive by 4.0% during the 4th quarter. Bailard Inc. now owns 8,192 shares of the company’s stock valued at $653,000 after acquiring an additional 317 shares during the period. Tokio Marine Asset Management Co. Ltd. raised its holdings in Colgate-Palmolive by 2.9% during the 4th quarter. Tokio Marine Asset Management Co. Ltd. now owns 34,510 shares of the company’s stock valued at $2,751,000 after acquiring an additional 965 shares during the period. Atria Wealth Solutions Inc. raised its holdings in Colgate-Palmolive by 1.3% during the 4th quarter. Atria Wealth Solutions Inc. now owns 39,394 shares of the company’s stock valued at $3,140,000 after acquiring an additional 500 shares during the period. Finally, Alaska Permanent Fund Corp raised its holdings in Colgate-Palmolive by 2.0% during the 4th quarter. Alaska Permanent Fund Corp now owns 150,892 shares of the company’s stock valued at $12,028,000 after acquiring an additional 2,959 shares during the period. Institutional investors own 80.41% of the company’s stock.

Insider Activity

In other news, CEO Noel R. Wallace sold 50,000 shares of the company’s stock in a transaction dated Monday, February 12th. The shares were sold at an average price of $83.15, for a total transaction of $4,157,500.00. Following the completion of the transaction, the chief executive officer now directly owns 274,179 shares of the company’s stock, valued at $22,797,983.85. The sale was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. In other news, CEO Noel R. Wallace sold 50,000 shares of the company’s stock in a transaction dated Monday, February 12th. The shares were sold at an average price of $83.15, for a total transaction of $4,157,500.00. Following the completion of the transaction, the chief executive officer now directly owns 274,179 shares of the company’s stock, valued at $22,797,983.85. The sale was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Also, insider Jennifer Daniels sold 61,633 shares of the stock in a transaction dated Thursday, February 1st. The stock was sold at an average price of $83.93, for a total transaction of $5,172,857.69. Following the completion of the transaction, the insider now directly owns 57,948 shares of the company’s stock, valued at $4,863,575.64. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 232,371 shares of company stock valued at $19,505,099. Insiders own 0.34% of the company’s stock.

Analyst Upgrades and Downgrades

CL has been the subject of a number of recent analyst reports. Raymond James upgraded shares of Colgate-Palmolive from a “market perform” rating to an “outperform” rating and set a $91.00 price target for the company in a research report on Monday, January 29th. Citigroup boosted their price target on shares of Colgate-Palmolive from $95.00 to $100.00 and gave the company a “buy” rating in a research report on Tuesday, April 16th. TheStreet upgraded shares of Colgate-Palmolive from a “c+” rating to a “b+” rating in a research report on Friday, January 26th. Morgan Stanley boosted their price target on shares of Colgate-Palmolive from $85.00 to $93.00 and gave the company an “overweight” rating in a research report on Monday, January 29th. Finally, UBS Group boosted their price target on shares of Colgate-Palmolive from $93.00 to $95.00 and gave the company a “buy” rating in a research report on Monday, January 29th. Three analysts have rated the stock with a hold rating and thirteen have issued a buy rating to the stock. Based on data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and an average target price of $89.50.

Colgate-Palmolive Trading Up 0.5 %

NYSE CL traded up $0.40 during trading on Thursday, hitting $89.27. 6,361,812 shares of the company’s stock traded hands, compared to its average volume of 4,572,863. The stock has a fifty day moving average of $87.40 and a two-hundred day moving average of $81.25. The company has a debt-to-equity ratio of 8.59, a current ratio of 1.11 and a quick ratio of 0.71. Colgate-Palmolive has a 12-month low of $67.62 and a 12-month high of $90.37. The firm has a market cap of $73.38 billion, a P/E ratio of 31.97, a PEG ratio of 3.33 and a beta of 0.42.

Colgate-Palmolive (NYSE:CL) last posted its quarterly earnings results on Friday, January 26th. The company reported $0.87 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.85 by $0.02. Colgate-Palmolive had a net margin of 11.82% and a return on equity of 509.75%. The business had revenue of $4.95 billion during the quarter, compared to analyst estimates of $4.89 billion. During the same period in the prior year, the business posted $0.77 earnings per share. The company’s revenue was up 6.9% on a year-over-year basis. As a group, sell-side analysts expect that Colgate-Palmolive will post 3.5 EPS for the current year.

Colgate-Palmolive Increases Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Wednesday, May 15th. Stockholders of record on Monday, April 22nd will be paid a dividend of $0.50 per share. This represents a $2.00 annualized dividend and a dividend yield of 2.24%. This is an increase from Colgate-Palmolive’s previous quarterly dividend of $0.48. The ex-dividend date is Friday, April 19th. Colgate-Palmolive’s dividend payout ratio is 71.94%.

About Colgate-Palmolive

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.